DE69612056D1 - Terpenderivate (sarcodictyine) als antikrebsmittel - Google Patents

Terpenderivate (sarcodictyine) als antikrebsmittel

Info

Publication number
DE69612056D1
DE69612056D1 DE69612056T DE69612056T DE69612056D1 DE 69612056 D1 DE69612056 D1 DE 69612056D1 DE 69612056 T DE69612056 T DE 69612056T DE 69612056 T DE69612056 T DE 69612056T DE 69612056 D1 DE69612056 D1 DE 69612056D1
Authority
DE
Germany
Prior art keywords
derivatives
sarcodictyine
anticrecellent
terpen
sarcodictyins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69612056T
Other languages
English (en)
Other versions
DE69612056T2 (de
Inventor
Carlo Battistini
Marina Ciomei
Francesco Pietra
Ambrosio Michele D
Antonio Guerriero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Publication of DE69612056D1 publication Critical patent/DE69612056D1/de
Application granted granted Critical
Publication of DE69612056T2 publication Critical patent/DE69612056T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69612056T 1995-05-16 1996-04-23 Terpenderivate (sarcodictyine) als antikrebsmittel Expired - Fee Related DE69612056T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9509888.5A GB9509888D0 (en) 1995-05-16 1995-05-16 Terpenoidic derivatives useful as antitumour agents
PCT/EP1996/001688 WO1996036335A1 (en) 1995-05-16 1996-04-23 Terpenoidic derivatives (sarcodictyins) useful as antitumor agents

Publications (2)

Publication Number Publication Date
DE69612056D1 true DE69612056D1 (de) 2001-04-19
DE69612056T2 DE69612056T2 (de) 2001-08-23

Family

ID=10774540

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69612056T Expired - Fee Related DE69612056T2 (de) 1995-05-16 1996-04-23 Terpenderivate (sarcodictyine) als antikrebsmittel

Country Status (23)

Country Link
US (2) US5869514A (de)
EP (1) EP0773782B1 (de)
JP (1) JPH10503218A (de)
KR (1) KR100420018B1 (de)
AT (1) ATE199641T1 (de)
AU (1) AU717028B2 (de)
CA (1) CA2194463A1 (de)
DE (1) DE69612056T2 (de)
DK (1) DK0773782T3 (de)
ES (1) ES2159357T3 (de)
GB (1) GB9509888D0 (de)
GR (1) GR3035982T3 (de)
HU (1) HUP9702443A3 (de)
IL (1) IL118218A (de)
MX (1) MX9700359A (de)
NO (1) NO312614B1 (de)
NZ (1) NZ307540A (de)
PL (1) PL183644B1 (de)
PT (1) PT773782E (de)
RU (1) RU2179441C2 (de)
UA (1) UA45974C2 (de)
WO (1) WO1996036335A1 (de)
ZA (1) ZA963784B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965718A (en) * 1997-10-24 1999-10-12 The Scripps Research Institute Analogs of sarcodictyin and eleutherobin
US6172205B1 (en) * 1997-12-11 2001-01-09 The Trustees Of Columbia In The City Of New York Synthetic process toward total synthesis of eleutherobin and its analogues and uses thereof
CA2323439A1 (en) * 1998-03-16 1999-09-23 Cytovia, Inc. Dipeptide caspase inhibitors and the use thereof
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
CA2290316A1 (en) 1999-11-24 2001-05-24 The University Of British Columbia Novel source of eleutherobin and related antimitotic diterpenes
BR0114713A (pt) * 2000-10-16 2004-01-13 Neopharm Inc Formulação lipossÈmica de mitoxantrona
US7067494B2 (en) * 2001-06-22 2006-06-27 The University Of British Columbia Antimitotic eleuthesides
GB0122257D0 (en) * 2001-09-14 2001-11-07 Pharmacia & Upjohn Spa Simplified sarcodictyin derivatives
GB0131034D0 (en) * 2001-12-28 2002-02-13 Pharmacia & Upjohn Spa Benzocyclodecane derivatives with antitumor activity
JP4364554B2 (ja) * 2002-06-07 2009-11-18 株式会社ルネサステクノロジ スイッチング電源装置及びスイッチング電源システム

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861776A (en) * 1987-01-30 1989-08-29 Syntex (U.S.A) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof, compositions and use
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPH10503218A (ja) 1998-03-24
ES2159357T3 (es) 2001-10-01
ATE199641T1 (de) 2001-03-15
CA2194463A1 (en) 1996-11-21
AU717028B2 (en) 2000-03-16
HUP9702443A2 (hu) 1998-06-29
PL183644B1 (pl) 2002-06-28
IL118218A (en) 1999-10-28
NZ307540A (en) 1998-02-26
MX9700359A (es) 1997-04-30
RU2179441C2 (ru) 2002-02-20
US5922750A (en) 1999-07-13
UA45974C2 (uk) 2002-05-15
AU5691796A (en) 1996-11-29
NO970178D0 (no) 1997-01-15
GB9509888D0 (en) 1995-07-12
US5869514A (en) 1999-02-09
WO1996036335A1 (en) 1996-11-21
KR100420018B1 (ko) 2004-05-31
KR970704436A (ko) 1997-09-06
NO312614B1 (no) 2002-06-10
IL118218A0 (en) 1996-09-12
GR3035982T3 (en) 2001-08-31
DE69612056T2 (de) 2001-08-23
EP0773782A1 (de) 1997-05-21
NO970178L (no) 1997-01-15
HUP9702443A3 (en) 2000-08-28
EP0773782B1 (de) 2001-03-14
ZA963784B (en) 1997-11-13
PT773782E (pt) 2001-08-30
PL318130A1 (en) 1997-05-12
DK0773782T3 (da) 2001-06-25

Similar Documents

Publication Publication Date Title
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
PT902789E (pt) Derivados de androsteno
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
DE60033649D1 (de) Verbindungen und therapeutische methoden
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ES2144054T3 (es) Complejos de tri(platino).
TR200100637T2 (tr) Yeni doğal ürün türevleri
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА
TR199901385T2 (xx) Piperidin t�revleri.
TR200000916T2 (tr) İkameli piperidin türevleri.
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PHARMACIA ITALIA S.P.A., MAILAND/MILANO, IT

8339 Ceased/non-payment of the annual fee